Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06570330 · ClinicalTrials.gov registry record · NA
Adult HMO Supplementation and the Gut Microbiome
A NA study, sponsored by Seeding.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT06570330 is a NA study that has completed, run by Seeding. The registered enrollment target is 32 participants.
The verdict
NCT06570330, a NA study, has completed, sponsored by Seeding.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
The goal of this study is to assess the impact of Layer Origin's SuperHMO prebiotic formulation on the healthy adult gut microbiome. Over the course of 30 days, intervention participants will take SuperHMO prebiotic formulation daily. Control participants will take a placebo daily. We will measure all participants\' gut microbiome using a gut health test before taking SuperHMO prebiotic or placebo and after 30 days of taking the supplement. We hypothesize that taking the SuperHMO prebiotic will improve gut health measurements such as the potential to produce short-chain fatty acids.
Interventions
- DIETARY_SUPPLEMENT SuperHMO
- DIETARY_SUPPLEMENT Non-GMO corn Maltodextrin, Rapid Absorption
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2024-08-22 |
| Est. Completion | 2025-07-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06570330
The ClinicalTrials.gov registry entry for NCT06570330 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Seeding, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which SuperHMO is the first listed.
NCT06570330 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06570330 about?
NCT06570330 is a clinical study titled "Adult HMO Supplementation and the Gut Microbiome". The goal of this study is to assess the impact of Layer Origin's SuperHMO prebiotic formulation on the healthy adult gut microbiome. Over the course of 30 days, intervention participants will take SuperHMO prebiotic formulation daily. Control participants will take a placebo daily. We will measure a...
What is the current status of trial NCT06570330?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2024-08-22. Estimated completion is 2025-07-30.
What interventions are being tested in trial NCT06570330?
The interventions under investigation include: SuperHMO (DIETARY_SUPPLEMENT), Non-GMO corn Maltodextrin, Rapid Absorption (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06570330?
This trial is sponsored by Seeding, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.